Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances

Bertrand L. Jaber, Brigitte Schiller, John M. Burkart, Rachid Daoui, Michael Kraus, Yoojin Lee, Brent W. Miller, Isaac Teitelbaum, Amy W. Williams, Fredric O. Finkelstein

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Summary Background and objectives Restless legs syndrome (RLS) and sleep disturbances are common among in-center hemodialysis patients and are associated with increased morbidity/mortality. Design, setting, participants, & measurements The FREEDOM study is an ongoing prospective cohort study investigating the benefits of home short daily hemodialysis (SDHD) (6 times/week). In this interim report, we examine the long-term effect of SDHD on the prevalence and severity of RLS, as measured by the International Restless Legs Syndrome (IRLS) Study Group rating scale, and sleep disturbances, as measured by the Medical Outcomes Study sleep survey. Results 235 participants were included in this report (intention-to-treat cohort), of which 127 completed the 12-month follow-up (per-protocol cohort). Mean age was 52 years, 55% had an arteriovenous fistula, and 40% suffered from RLS. In the per-protocol analysis, among patients with RLS, the mean IRLS score improved significantly at month 12, after adjustment for use of RLS-related medications (18 versus 11). Among patients with moderate-to-severe RLS (IRLS score ≥15), there was an even greater improvement in the IRLS score (23 versus 13). The intention-to-treat analysis yielded similar results. Over 12 months, there was decline in the percentage of patients reporting RLS (35% versus 26%) and those reporting moderate-to-severe RLS (59% versus 43%). There was a similar and sustained 12-month improvement in several scales of the sleep survey, after adjustment for presence of RLS and use of anxiolytics and hypnotics. Conclusions Home SDHD is associated with long-term improvement in the prevalence and severity of RLS and sleep disturbances.& copy 2011 by the American Society of Nephrology.

Original languageEnglish
Pages (from-to)1049-1056
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Volume6
Issue number5
DOIs
StatePublished - May 1 2011

Fingerprint

Restless Legs Syndrome
Renal Dialysis
Sleep
Intention to Treat Analysis
Anti-Anxiety Agents
Arteriovenous Fistula
Hypnotics and Sedatives

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Jaber, B. L., Schiller, B., Burkart, J. M., Daoui, R., Kraus, M., Lee, Y., ... Finkelstein, F. O. (2011). Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clinical Journal of the American Society of Nephrology, 6(5), 1049-1056. https://doi.org/10.2215/CJN.10451110

Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. / Jaber, Bertrand L.; Schiller, Brigitte; Burkart, John M.; Daoui, Rachid; Kraus, Michael; Lee, Yoojin; Miller, Brent W.; Teitelbaum, Isaac; Williams, Amy W.; Finkelstein, Fredric O.

In: Clinical Journal of the American Society of Nephrology, Vol. 6, No. 5, 01.05.2011, p. 1049-1056.

Research output: Contribution to journalArticle

Jaber, BL, Schiller, B, Burkart, JM, Daoui, R, Kraus, M, Lee, Y, Miller, BW, Teitelbaum, I, Williams, AW & Finkelstein, FO 2011, 'Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances', Clinical Journal of the American Society of Nephrology, vol. 6, no. 5, pp. 1049-1056. https://doi.org/10.2215/CJN.10451110
Jaber, Bertrand L. ; Schiller, Brigitte ; Burkart, John M. ; Daoui, Rachid ; Kraus, Michael ; Lee, Yoojin ; Miller, Brent W. ; Teitelbaum, Isaac ; Williams, Amy W. ; Finkelstein, Fredric O. / Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. In: Clinical Journal of the American Society of Nephrology. 2011 ; Vol. 6, No. 5. pp. 1049-1056.
@article{d4be7b92b2004879aee39b70fe1f9b3d,
title = "Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances",
abstract = "Summary Background and objectives Restless legs syndrome (RLS) and sleep disturbances are common among in-center hemodialysis patients and are associated with increased morbidity/mortality. Design, setting, participants, & measurements The FREEDOM study is an ongoing prospective cohort study investigating the benefits of home short daily hemodialysis (SDHD) (6 times/week). In this interim report, we examine the long-term effect of SDHD on the prevalence and severity of RLS, as measured by the International Restless Legs Syndrome (IRLS) Study Group rating scale, and sleep disturbances, as measured by the Medical Outcomes Study sleep survey. Results 235 participants were included in this report (intention-to-treat cohort), of which 127 completed the 12-month follow-up (per-protocol cohort). Mean age was 52 years, 55{\%} had an arteriovenous fistula, and 40{\%} suffered from RLS. In the per-protocol analysis, among patients with RLS, the mean IRLS score improved significantly at month 12, after adjustment for use of RLS-related medications (18 versus 11). Among patients with moderate-to-severe RLS (IRLS score ≥15), there was an even greater improvement in the IRLS score (23 versus 13). The intention-to-treat analysis yielded similar results. Over 12 months, there was decline in the percentage of patients reporting RLS (35{\%} versus 26{\%}) and those reporting moderate-to-severe RLS (59{\%} versus 43{\%}). There was a similar and sustained 12-month improvement in several scales of the sleep survey, after adjustment for presence of RLS and use of anxiolytics and hypnotics. Conclusions Home SDHD is associated with long-term improvement in the prevalence and severity of RLS and sleep disturbances.& copy 2011 by the American Society of Nephrology.",
author = "Jaber, {Bertrand L.} and Brigitte Schiller and Burkart, {John M.} and Rachid Daoui and Michael Kraus and Yoojin Lee and Miller, {Brent W.} and Isaac Teitelbaum and Williams, {Amy W.} and Finkelstein, {Fredric O.}",
year = "2011",
month = "5",
day = "1",
doi = "10.2215/CJN.10451110",
language = "English",
volume = "6",
pages = "1049--1056",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances

AU - Jaber, Bertrand L.

AU - Schiller, Brigitte

AU - Burkart, John M.

AU - Daoui, Rachid

AU - Kraus, Michael

AU - Lee, Yoojin

AU - Miller, Brent W.

AU - Teitelbaum, Isaac

AU - Williams, Amy W.

AU - Finkelstein, Fredric O.

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Summary Background and objectives Restless legs syndrome (RLS) and sleep disturbances are common among in-center hemodialysis patients and are associated with increased morbidity/mortality. Design, setting, participants, & measurements The FREEDOM study is an ongoing prospective cohort study investigating the benefits of home short daily hemodialysis (SDHD) (6 times/week). In this interim report, we examine the long-term effect of SDHD on the prevalence and severity of RLS, as measured by the International Restless Legs Syndrome (IRLS) Study Group rating scale, and sleep disturbances, as measured by the Medical Outcomes Study sleep survey. Results 235 participants were included in this report (intention-to-treat cohort), of which 127 completed the 12-month follow-up (per-protocol cohort). Mean age was 52 years, 55% had an arteriovenous fistula, and 40% suffered from RLS. In the per-protocol analysis, among patients with RLS, the mean IRLS score improved significantly at month 12, after adjustment for use of RLS-related medications (18 versus 11). Among patients with moderate-to-severe RLS (IRLS score ≥15), there was an even greater improvement in the IRLS score (23 versus 13). The intention-to-treat analysis yielded similar results. Over 12 months, there was decline in the percentage of patients reporting RLS (35% versus 26%) and those reporting moderate-to-severe RLS (59% versus 43%). There was a similar and sustained 12-month improvement in several scales of the sleep survey, after adjustment for presence of RLS and use of anxiolytics and hypnotics. Conclusions Home SDHD is associated with long-term improvement in the prevalence and severity of RLS and sleep disturbances.& copy 2011 by the American Society of Nephrology.

AB - Summary Background and objectives Restless legs syndrome (RLS) and sleep disturbances are common among in-center hemodialysis patients and are associated with increased morbidity/mortality. Design, setting, participants, & measurements The FREEDOM study is an ongoing prospective cohort study investigating the benefits of home short daily hemodialysis (SDHD) (6 times/week). In this interim report, we examine the long-term effect of SDHD on the prevalence and severity of RLS, as measured by the International Restless Legs Syndrome (IRLS) Study Group rating scale, and sleep disturbances, as measured by the Medical Outcomes Study sleep survey. Results 235 participants were included in this report (intention-to-treat cohort), of which 127 completed the 12-month follow-up (per-protocol cohort). Mean age was 52 years, 55% had an arteriovenous fistula, and 40% suffered from RLS. In the per-protocol analysis, among patients with RLS, the mean IRLS score improved significantly at month 12, after adjustment for use of RLS-related medications (18 versus 11). Among patients with moderate-to-severe RLS (IRLS score ≥15), there was an even greater improvement in the IRLS score (23 versus 13). The intention-to-treat analysis yielded similar results. Over 12 months, there was decline in the percentage of patients reporting RLS (35% versus 26%) and those reporting moderate-to-severe RLS (59% versus 43%). There was a similar and sustained 12-month improvement in several scales of the sleep survey, after adjustment for presence of RLS and use of anxiolytics and hypnotics. Conclusions Home SDHD is associated with long-term improvement in the prevalence and severity of RLS and sleep disturbances.& copy 2011 by the American Society of Nephrology.

UR - http://www.scopus.com/inward/record.url?scp=79957839761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957839761&partnerID=8YFLogxK

U2 - 10.2215/CJN.10451110

DO - 10.2215/CJN.10451110

M3 - Article

C2 - 21415315

AN - SCOPUS:79957839761

VL - 6

SP - 1049

EP - 1056

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 5

ER -